BridgeMD
New treatment option for Conduction System Pacing
Official title Physiological Pacing for AV Block to Prevent Pacemaker-induced Cardiomyopathy
ClinicalTrials.gov ID: NCT05214365
What this study is testing
- What it's testing
- The implantation of a pacemaker and conventional cardiac pacing from the right ventricle (apex or septum) is an effective and safe therapy for the treatment of patients with atrioventricular block and bradycardia.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- The patient must be ≥ 18 years of age.
- The patient must indicate their acceptance to participate in the study by signing an informed consent document.
- Patients with EF\> 50% and indication for pacemaker implantation due to atrial-ventricular block according to current clinical guidelines.
You likely can't join if
- Inability to understand and sign the informed consent.
- Patients with severe comorbidities and life expectancy \<1 year.
- Patients with severe cognitive impairment or other comorbidities resulting in dependence for basic activities of daily life.
- Patients who cannot come to our center to carry out the follow-up of the study.
The study team makes the final eligibility decision.
Where it's taking place
- Barcelona, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barcelona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.